ESPIcurrent report No. 4 / 2021Legalbasis:Art. 17 sec. 1 of MAR -confidential informationPublicChancellerySubject:Signing a letter of intent by the Issuer'ssubsidiaryCARLSONINVESTMENTS S.A. Management Board with its registered office in Warsaw(the Company, the Issuer), hereby informs that the Issuer's subsidiaryCARLSON INVESTMENTS ALTERNATYWNA SPÓŁKA INWESTYCYJNA S.A. (being in theorganization), on March 25, 2021, it signed a letter of intent withTerrabio Sp. z o.o.Thesubject of the signed letter of intent is the commencement of goodwillnegotiations and determination of the final terms of the capitalinvestment made by CARLSON INVESMENTS ASI S.A. and specified in themaximum amount of PLN 4,000,000 (say: four million zlotys) into theTerrabio Sp. z o.o. The letter of intent and its provisions oblige theparties to make further specific arrangements during the negotiationsand the validity of this agreement, ie 3 consecutive calendar monthsfrom the date of its signing.TerrabioSp. z o.o. offers quick diagnostics in the field of plant diseases,water and food safety. The team of Terrabio Sp. z o.o. created byoutstanding experts with a narrow field of specialization with mindsopen to new ideas and innovative technologies. Thanks to the cooperationof young ambitious scientists, commercialization specialists andmanagement staff, the company is building its position on the moleculardiagnostics market.http://terrabio.tech/TheIssuer will inform about the next stages of the negotiations and thefinal result in a separate report.